1. Home
  2. MNDY vs BIO Comparison

MNDY vs BIO Comparison

Compare MNDY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDY
  • BIO
  • Stock Information
  • Founded
  • MNDY 2012
  • BIO 1952
  • Country
  • MNDY Israel
  • BIO United States
  • Employees
  • MNDY N/A
  • BIO N/A
  • Industry
  • MNDY Computer Software: Prepackaged Software
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • MNDY Technology
  • BIO Industrials
  • Exchange
  • MNDY Nasdaq
  • BIO Nasdaq
  • Market Cap
  • MNDY 9.5B
  • BIO 8.6B
  • IPO Year
  • MNDY 2021
  • BIO N/A
  • Fundamental
  • Price
  • MNDY $205.24
  • BIO $319.55
  • Analyst Decision
  • MNDY Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • MNDY 21
  • BIO 4
  • Target Price
  • MNDY $298.19
  • BIO $358.50
  • AVG Volume (30 Days)
  • MNDY 826.7K
  • BIO 259.2K
  • Earning Date
  • MNDY 11-10-2025
  • BIO 10-29-2025
  • Dividend Yield
  • MNDY N/A
  • BIO N/A
  • EPS Growth
  • MNDY N/A
  • BIO N/A
  • EPS
  • MNDY 0.76
  • BIO N/A
  • Revenue
  • MNDY $1,100,240,000.00
  • BIO $2,557,500,000.00
  • Revenue This Year
  • MNDY $28.70
  • BIO $2.05
  • Revenue Next Year
  • MNDY $22.30
  • BIO $2.86
  • P/E Ratio
  • MNDY $269.16
  • BIO N/A
  • Revenue Growth
  • MNDY 30.24
  • BIO N/A
  • 52 Week Low
  • MNDY $166.22
  • BIO $211.43
  • 52 Week High
  • MNDY $342.64
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • MNDY 59.85
  • BIO 54.46
  • Support Level
  • MNDY $192.61
  • BIO $298.22
  • Resistance Level
  • MNDY $202.31
  • BIO $343.12
  • Average True Range (ATR)
  • MNDY 7.27
  • BIO 13.37
  • MACD
  • MNDY 2.25
  • BIO -1.64
  • Stochastic Oscillator
  • MNDY 92.39
  • BIO 47.51

About MNDY monday.com Ltd.

Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: